cutaneous neurofibromas
Showing 1 - 25 of 1,611
Neurofibromatosis 1 Trial in Boston (Deoxycholic Acid, Polidocanol, 1064nm Nd:YAG laser)
Not yet recruiting
- Neurofibromatosis 1
- Deoxycholic Acid
- +3 more
-
Boston, MassachusettsWellman Center for Photomedicine
Nov 13, 2023
Cutaneous Neurofibromas in People With NF1
Recruiting
- Neurofibromatosis Type 1
- +3 more
- Evaluation of the natural history of cutaneous neurofibromas
-
Baltimore, MarylandJohns Hopkins University
Oct 12, 2022
Cutaneous Neurofibroma Trial in Boston (Kybella, 980nm laser, 755nm Alexandrite Laser)
Recruiting
- Cutaneous Neurofibroma
- Kybella
- +3 more
-
Boston, MassachusettsWellman Center for Photomedicine, Massachusetts General Hospital
Aug 10, 2022
Cutaneous Neurofibroma Trial in New York (DPCP)
Not yet recruiting
- Cutaneous Neurofibroma
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jun 24, 2022
Neurofibromatosis 1 Trial in Baltimore, Redwood City
Recruiting
- Neurofibromatosis 1
-
Baltimore, California
- +1 more
Aug 17, 2022
Cutaneous Neurofibroma Trial in Copenhagen, Gothenburg (TOOsonix System ONE-M)
Active, not recruiting
- Cutaneous Neurofibroma
- TOOsonix System ONE-M
-
Copenhagen, Hovedstaden, Denmark
- +1 more
Jun 23, 2022
Cutaneous Neurofibroma, Neurofibromatosis 1 Trial in United States (NFX-179 gel, Vehicle gel)
Recruiting
- Cutaneous Neurofibroma
- Neurofibromatosis 1
- NFX-179 gel
- Vehicle gel
-
Little Rock, Arkansas
- +22 more
Jan 18, 2023
NEUROFIBROMATOSIS 1 Trial in Milwaukee (aminolevulinic acid)
Recruiting
- NEUROFIBROMATOSIS 1
- aminolevulinic acid
-
Milwaukee, WisconsinThe Medical College of Wisconsin
Nov 30, 2021
Neurofibromatosis 1 Trial (curcumin, high phenolic extra virgin olive oil (HP-EVOO))
Recruiting
- Neurofibromatosis 1
- curcumin, high phenolic extra virgin olive oil (HP-EVOO)
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Aug 23, 2022
Neurofibromatoses Trial in Milwaukee (Part 1 Levulan injection, Part 1 Levulan surface application, Part 1 Levulan surface
Completed
- Neurofibromatoses
- Part 1 Levulan injection
- +6 more
-
Milwaukee, WisconsinThe Medical College of Wisconsin
Jun 16, 2021
Neurofibromatosis 1, Plexiform Neurofibroma, NF1 Trial (Test group (Group A): FCN-159 8 mg, orally, once daily;, Control group
Not yet recruiting
- Neurofibromatosis 1
- +2 more
- Test group (Group A): FCN-159 8 mg, orally, once daily;
- Control group (Group B): Placebo, orally, once daily;
- (no location specified)
Jun 16, 2023
Neurofibromatosis 1, Plexiform Neurofibroma (PN) Trial in Worldwide (Selumetinib, Placebo)
Recruiting
- Neurofibromatosis 1
- Plexiform Neurofibroma (PN)
- Selumetinib
- Placebo
-
Gainesville, Florida
- +40 more
Jan 16, 2023
Neurofibroma, Neurofibroma, Plexiform Trial (Cryotherapy)
Not yet recruiting
- Neurofibroma
- Neurofibroma, Plexiform
- Cryotherapy
- (no location specified)
Jan 19, 2022
Neurofibromatosis 1, Neurofibroma Plexiform Trial in Shanghai (Selumetinib)
Active, not recruiting
- Neurofibromatosis 1
- Neurofibroma Plexiform
-
Shanghai, China
- +1 more
Jan 13, 2023
Plexiform Neurofibroma, Neurofibromatosis Type 1 (NF1) Trial in United States (Mirdametinib (PD-0325901) oral capsule or
Active, not recruiting
- Plexiform Neurofibroma
- Neurofibromatosis Type 1 (NF1)
- Mirdametinib (PD-0325901) oral capsule or dispersible tablet
-
Birmingham, Alabama
- +49 more
Nov 17, 2022
RAS Mutation, Neurofibromatosis 1, Noonan Syndrome Trial in Cincinnati
Recruiting
- RAS Mutation
- +13 more
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Feb 24, 2022
Neurofibromatosis 1 Trial run by the National Cancer Institute (NCI) (Abemaciclib)
Recruiting
- Neurofibromatosis 1
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
US Selumetinib Registry
Not yet recruiting
- Neurofibromatosis Type 1
- Plexiform Neurofibromas
- (no location specified)
Jan 5, 2023
Needs and Preferences of Patients With Head-neck Cutaneous SCC
Active, not recruiting
- Cutaneous Squamous Cell Carcinoma
- +10 more
- Regular care with additional administration of a semi-structured interview
-
Maastricht, NetherlandsMaastricht University Medical Center+
Sep 13, 2023
Mycosis Fungoides of Skin (Diagnosis), Cutaneous T-cell Lymphoma, Non Hodgkin Lymphoma Trial in Cleveland (Med-Jet Injector,
Not yet recruiting
- Mycosis Fungoides of Skin (Diagnosis)
- +5 more
- Med-Jet Injector
- +4 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 17, 2023
Discoid Lupus Erythematosus Trial in Cairo (Nicotinamide Topical)
Completed
- Discoid Lupus Erythematosus
- Nicotinamide Topical
-
Cairo, EgyptAL-Azhar University Hospital
Oct 22, 2022
Total Knee Replacement, Genicular Nerve Block, Opioid Use Trial in New York (Bupivacaine Injection, Dexamethasone injection)
Recruiting
- Total Knee Replacement
- +2 more
- Bupivacaine Injection
- Dexamethasone injection
-
New York, New YorkHospital for Special Surgery
Jul 31, 2023